2 class -- Vioxx, which Merck decided on its own to withdraw, Celebrex, made by Pfizer Inc. under the generic name celecoxib, and Pfizer's Bextra or valdecoxib.
The drugs are successful because they are designed to be taken long-term by patients (...)
